L'Oreal buys British skincare brand Medik8
is to acquire British skincare brand
Medik8
, its owner, Britain-based private equity firm Inflexion, said on Monday, boosting the French cosmetics giant's offering in the fast-growing dermatological
skincare market
.
The size of the deal was not disclosed. Medik8 focuses on vitamin A-based anti-ageing creams and serums.
"The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement.
L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay, and SkinCeuticals, has been its fastest growing in recent years, reaching revenues of 7 billion euros (USD 7.99 billion) last year, after growing almost 10% on the year before.
The business, which also has the highest profit margin among its four divisions, has boomed on growing consumer interest in science-backed products, though growth has slowed recently due to rising competition.
L'Oreal executives said this year they were pursuing acquisitions and looking to revive flagging growth. The company acquired Korean skincare brand, Dr.G, in December and also bought a minority stake in Oman-based perfume house Amourage last year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
10 minutes ago
- New Indian Express
UP Man alleges 'towel-size' medical gauze found inside wife's body weeks after cesarean delivery
The pathology lab conducted the ultrasound test and then asked for an X-ray test, and subsequently a scan. "I gradually started feeling afraid and thought, why is the matter escalating?" he said. Kataria's fears worsened seeing the urgency with which the pathology lab carried out the CT-scan. He said an existing patient's test was stopped midway and his wife's CT-scan was conducted. He further said that when he asked the pathology lab to give him the reports, they refused and told him to first consult the gynaecologist, Sirohi. "When I reached the doctor's clinic, she was adamant about conducting a surgery. When I said that your nursing home is not equipped to conduct surgery, she said that she will remove the pus-like material using a syringe," he said. Kataria said he wanted a second opinion but Sirohi allegedly said there was no need for it and that his wife was "like a sister". Kataria also claimed that the pathologist tried every trick in the book to not give the report to him and relented only when he threatened to involve the police. He then took the appointment of another Ghaziabad-based doctor but claimed that by the time he reached her clinic, Sirohi had already called her "to not entertain" him. "My fears intensified. I asked the second doctor whether my wife needs to be admitted. She said that my wife must be admitted that very night itself, and there was no guarantee (of her being alive) the next day," Kataria said. "I realised that I have to admit my wife to a hospital in Delhi, and on the night of July 10, I took my wife and admitted her to a hospital in Patparganj (Delhi). Here, all tests were conducted on the night of July 10 itself. They could clearly see a foreign body in the tests," he said. Kataria said a surgery was planned for the next day (July 11). "After the surgery, which lasted for around 3 hours, a medical gauze, the size of a towel, was retrieved from inside my wife's body. Since that piece of cloth was inside her body for one-and-a-half months, it was attached to the ovary and other parts of the body," he claimed. Khurana was finally discharged on July 14, he said. Kataria said he has been getting calls from people saying that the Sirohis are influential people, and they dissuaded him from fighting them as it would be a long battle. "On July 16, I lodged a complaint with the chief medical officer. On July 17, I lodged a police complaint. Initially, the CMO assured me that he will take action against the doctor, but later he backtracked. A DCP-ranked officer, after five days, also said that an FIR be registered in the case, and issued instructions to the police station. When the copy of the complaint reached the CMO, he alleged "the CMO made a U-turn", saying his wife has not died while others have lost their wives and that their complaints are still pending for the past six months. "The CMO said that he wants to give one chance to the doctor (Sirohi)," Kataria said. When contacted, Ghaziabad Chief Medical Officer Dr Akhilesh Mohan on Monday told PTI, "A three-member team, which includes a gynaecologist, has been constituted to probe the matter. I have written a letter to the nursing home, where the treatment (cesarean delivery) was done. As soon as I get the letter, action will be taken." Dr Nishi Sirohi said she has received a letter from the CMO on the matter 3-4 days ago and that she has given her reply. "I feel that the person (Chirag Kataria) is speaking baseless things. The patient went from here in a proper condition. And (later), I told her that there is some pus in her stomach, and she should be admitted, so that treatment can be done after carrying out tests," she told PTI. "They did not come to me. And, now after one and a half months, I am getting this letter from the CMO. I will fully cooperate in the probe," she added.
The Wire
10 minutes ago
- The Wire
'Not a Side Effect of War': Israeli Human Rights Groups Say Israel Committing Genocide in Gaza
New Delhi: In a first, Tel Aviv-based human rights organisations, B'Tsalem and Physicians for Human Rights Israel, have released statements calling out Israel for committing the genocide of Palestinians in Gaza. They have said that Israel has systematically and deliberately targeted Palestinians and that its western allies have the power to stop it. In both their statements, the leading human rights groups have noted that Israel's policy towards Palestinians shifted on October 13, 2023, which marked the beginning of a military onslaught lasting more than 21 months and counting. B'Tsalem stated that it has resulted in mass killing, both directly and through creating unlivable conditions, serious bodily or mental harm to an entire population, decimation of basic infrastructure throughout the Gaza Strip, and forcible displacement on a huge scale, with ethnic cleansing added to the list of official war objectives. "The mass arrests and abuse of Palestinians in Israeli prisons, which have effectively become torture camps, and tearing apart the social fabric of Gaza, including the destruction of Palestinian educational and cultural institutions, compound it. The campaign is also an assault on Palestinian identity itself, through the deliberate destruction of refugee camps and attempts to undermine the United Nations Relief and Works Agency for Palestine Refugees (UNRWA)," it stated. The group also highlighted the failure of the international community in stopping the atrocities, especially the leaders of the Western world, particularly the United States and Europe, who, it said, "share responsibility by providing support that enables Israel's acts of destruction". Meanwhile, Physicians for Human Rights' statement focused on the starvation and killing of children by the Israeli occupation. "Each day, dozens die of malnutrition. Ninety-two percent of infants aged six months to two years don't get enough to eat. At least 85 children have already starved to death. Israel has displaced 9 in 10 Gazans, destroyed or damaged 92% of homes, and left over half a million children without schools or stability. It has wiped out essential health services – including dialysis, maternal care, cancer treatment, and diabetes management," it stated. The organisation said that this was not temporary but a "strategy to eliminate the conditions needed for life". "Even if Israel stops the offensive today, the destruction it has inflicted guarantees that preventable deaths – from starvation, infection, and chronic illness – will continue for years. This is not collateral damage. This is not a side effect of war. It is the systematic creation of unlivable conditions. It is the denial of survivability. It is a genocide," it stated. B'Tsalem further warned that this genocide will not remain confined to the Gaza Strip, and that the actions and underlying mindset driving it may be extended to other areas as well. "The recognition that the Israeli regime is committing genocide in the Gaza Strip, and the deep concern that it may expand to other areas where Palestinians live under Israeli rule, demand urgent and unequivocal action from both Israeli society and the international community," it said. The groups have urged international community to fulfil its duty Ito stop the genocide Israel is carrying out in Gaza. The death toll in Gaza now stands close to 60,000, as per the health ministry data, and the remaining population is on the verge of famine. Over the weekend, Israel announced a few measures to allow aid access, including a limited 10-hour daily "tactical pause" in certain areas of Gaza City. However, there have also been reports Israeli attacks taking place where people were trying to collect aid.
&w=3840&q=100)
Business Standard
10 minutes ago
- Business Standard
UltraTech lines up ₹10,000 cr capex for FY26 to bolster capacity
Cement maker UltraTech, which expects around 7 per cent growth in FY26, has allocated up to Rs 10,000 crore as capex to bolster its capacity as well as energy and efficiency initiatives, according to the company's latest annual report. The Aditya Birla group firm recently acquired South-based India Cements and the cement business of Kesoram Industries, and added 26.3 MTPA of grey cement capacity to its portfolio. It has planned an organic capacity addition of 28.8 MTPA by FY27. UltraTech, which crossed the Rs 75,000 crore revenue mark in FY25 and is now very close to 200 MTPA (million tonnes per annum) capacity, anticipate a reduction in "net debt to EBITDA ratio", helped by a higher volume growth and improving margins. "Although our net debt to EBITDA (pre-tax profit) ratio rose to 1.33x in March 2025, we anticipate higher volume growth and an improving EBITDA profile to reduce this rapidly," its Managing Director K C Jhanwar said while addressing the shareholders. Like other cement makers, UltraTech also faced a lowered sales realisation amidst tepid demand conditions last year, which marginally declined its EBITDA (earnings before interest, taxes, depreciation and amortisation) compared with FY24. The cement demand has reached approximately 435 million tonnes in India, and with tailwinds such as continued government focus on infrastructure development, affordable housing, and urbanisation is expected to bolster the demand further, the company said. Moreover, the government in its Union Budget allocated Rs 11.21 lakh crore for the infrastructure sector, providing further tailwind to demand for cement. "While cement demand moderated to 4-5 per cent in FY 2024-25 owing to a temporary slowdown in government infrastructure spending and a prolonged monsoon, it is likely to rebound to 6-7 per cent in FY 2025-26," Jhanwar added. He further said UltraTech added 42.6 MTPA of consolidated grey cement capacity through organic and inorganic growth in FY25, taking total capacity to 188.8 MTPA. As of June 30, 2025, the company's consolidated capacity has reached 192.26 MTPA and is accelerating its journey towards the 200 MTPA capacity milestone, he added. On scaling up the capacity, Jhanwar said, besides acquisitions of India Cements and Kesoram Industries, the company has added 16.3 MTPA through organic expansions, which accounted for 55 per cent of India's total cement sector expansion in FY25, reinforcing its industry-leading position. On India Cements and Kesoram, he said the two entities have significantly strengthened our footprint in the attractive South India market. "We are unlocking further value through energy and efficiency initiatives. For instance, at the erstwhile Kesoram units, we are expanding green energy capacity by 107 MW to enhance operational efficiencies," he said. For India Cement, which achieved EBITDA break-even in the March 2025 quarter after efficiency improvements, UltraTech said "a capex plan is being made for investments over the next two years for improvement in all areas of operations to bring these assets at par with UltraTech standards". UltraTech is facing competition from Adani group firm Ambuja Cements, which is also adding capacity through acquisitions and pacing up organic capacity addition at existing units. It has crossed 100 MTPA capacity in FY25 in a record time, mainly through acquisitions, and now aims to reach 118 MTPA by FY2026 and 140 MTPA by FY2028. Adani Group, which jumped into the Cement sector in September 2022 after acquiring controlling stakes in Ambuja Cement from Swiss firm Holcim for cash proceeds of USD 6.4 billion (about Rs 51,000 crore), owns ACC Ltd. Later, it acquired small companies such as Hyderabad-based Penna Cement, Saurastra-based Sanghi Industries and Orient Cement from the CK Birla group. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
